MDT

88.42

-0.26%↓

VEEV

282.22

-0.26%↓

120.83

+0.49%↑

WBA

11.48

-0.09%↓

HQY

101.21

-1.67%↓

MDT

88.42

-0.26%↓

VEEV

282.22

-0.26%↓

120.83

+0.49%↑

WBA

11.48

-0.09%↓

HQY

101.21

-1.67%↓

MDT

88.42

-0.26%↓

VEEV

282.22

-0.26%↓

120.83

+0.49%↑

WBA

11.48

-0.09%↓

HQY

101.21

-1.67%↓

MDT

88.42

-0.26%↓

VEEV

282.22

-0.26%↓

120.83

+0.49%↑

WBA

11.48

-0.09%↓

HQY

101.21

-1.67%↓

MDT

88.42

-0.26%↓

VEEV

282.22

-0.26%↓

120.83

+0.49%↑

WBA

11.48

-0.09%↓

HQY

101.21

-1.67%↓

Home・Aktien・Thermo Fisher Scientific Inc

Thermo Fisher Scientific Inc

Geschlossen

BrancheGesundheitswesen

427.64 1.5

Buy Sell

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

420.71

Max

430.21

Schlüsselkennzahlen
By Trading Economics
Einkommen	-309M 1.5B
Verkäufe	-1B 10B
KGV Branchendurchschnitt	23.753 40.527
EPS	5.15
Dividendenrendite	0.42
Gewinnspanne	14.618
Angestellte	125,000
EBITDA	-1.3B 1.7B

Empfehlungen
By TipRanks
Empfehlungen	Starkes Kaufsignal
12-Monats-Prognose	+30.97% upside

Dividenden
By Dow Jones
Dividendenrendite Branchendurchschnitt	0.42% 2.40%
Nächstes Ergebnis	23. Juli 2025
Nächste Dividendenausschüttung	15. Juli 2025
Nächstes Ex-Dividendendatum	12. Sept. 2025

Marktstatistiken
By TradingEconomics
Marktkapitalisierung	-50B 153B
Vorheriger Eröffnungskurs	426.14
Vorheriger Schlusskurs	427.64

Nachrichtenstimmung

By Acuity

27%

73%

56 / 380 Ranking in Healthcare

Technischer Score

By Trading Central

Vertrauen

Bearish Evidence

406.5 / 417.79 Unterstützung & Widerstand

Thermo Fisher Scientific Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Peer-Vergleich

Kursveränderung

Thermo Fisher Scientific Inc Prognose

Kursziel

By TipRanks

30.97% Vorteil

12-Monats-Prognose

Durchschnitt 552 USD 30.97%

Hoch 620 USD

Tief 450 USD

Basierend auf 19 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Thermo Fisher Scientific Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Starkes Kaufsignal

19 ratings

Buy

Halten

Sell

Basierend auf 19 Analysten, die in den letzten 3 Monaten Aktienbewertungen für Thermo Fisher Scientific Inc – Dist abgegeben haben.

Technischer Score

By Trading Central

406.5 / 417.79Unterstützung & Widerstand

Recent bearish events outweigh bullish events.

There is one bearish event.

All events are bearish.

Stimmung

By Acuity

56 / 380 Ranking in Gesundheitswesen

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

Über Thermo Fisher Scientific Inc

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. It has a collaboration agreement with Mainz Biomed N.V. for the development of colorectal cancer screening product. Thermo Fisher Scientific Inc. was founded in 1956 and is headquar